The PROFILE feasibility study: targeted screening of men with a family history of prostate cancer
<p><strong>Background.</strong> A better assessment of individualized prostate cancer (PrCa) risk is needed to improve screening. The use of the prostate-specific antigen (PSA) level for screening in the general population has limitations and is not currently advocated. Approximate...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
AlphaMed Press
2016
|
| _version_ | 1797108922362888192 |
|---|---|
| author | Castro, E Mikropoulos, C Bancroft, EK Dadaev, T Goh, C Taylor, N Saunders, E Borley, N Keating, D Page, EC Saya, S Hazell, S Livni, N DeSouza, N Neal, D Hamdy, FC Kumar, P Antoniou, AC Kote-Jarai, Z PROFILE Study Steering Committee Eeles, RA |
| author_facet | Castro, E Mikropoulos, C Bancroft, EK Dadaev, T Goh, C Taylor, N Saunders, E Borley, N Keating, D Page, EC Saya, S Hazell, S Livni, N DeSouza, N Neal, D Hamdy, FC Kumar, P Antoniou, AC Kote-Jarai, Z PROFILE Study Steering Committee Eeles, RA |
| author_sort | Castro, E |
| collection | OXFORD |
| description | <p><strong>Background.</strong>
A better assessment of individualized prostate cancer (PrCa) risk is needed to improve screening. The use of the prostate-specific antigen (PSA) level for screening in the general population has limitations and is not currently advocated. Approximately 100 common single nucleotide polymorphisms (SNPs) have been identified that are associated with the risk of developing PrCa. The PROFILE pilot study explored the feasibility of using SNP profiling in men with a family history (FH) of PrCa to investigate the probability of detecting PrCa at prostate biopsy (PB). The primary aim of this pilot study was to determine the safety and feasibility of PrCa screening using transrectal ultrasound-guided PB with or without diffusion-weighted magnetic resonance imaging (DW-MRI) in men with a FH. A secondary aim was to evaluate the potential use of SNP profiling as a screening tool in this population.</p>
<p><strong>Patients and Methods.</strong>
A total of 100 men aged 40–69 years with a FH of PrCa underwent PB, regardless of their baseline PSA level. Polygenic risk scores (PRSs) were calculated for each participant using 71 common PrCa susceptibility alleles. We treated the disease outcome at PB as the outcome variable and evaluated its associations with the PRS, PSA level, and DW-MRI findings using univariate logistic regression.</p>
<p><strong>Results.</strong>
Of the 100 men, 25 were diagnosed with PrCa, of whom 12 (48%) had clinically significant disease. Four adverse events occurred and no deaths. The PSA level and age at study entry were associated with PrCa at PB (p = .00037 and p = .00004, respectively).
<p><strong>Conclusion.</strong>
The results of the present pilot study have demonstrated that PB is a feasible and safe method of PrCa screening in men with a FH, with a high proportion of PrCa identified requiring radical treatment. It is feasible to collect data on PrCa-risk SNPs to evaluate their combined effect as a potential screening tool. A larger prospective study powered to detect statistical associations is in progress.</p> |
| first_indexed | 2024-03-07T07:34:47Z |
| format | Journal article |
| id | oxford-uuid:5985ee3f-ba82-44cd-9894-a0e866e55da9 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:34:47Z |
| publishDate | 2016 |
| publisher | AlphaMed Press |
| record_format | dspace |
| spelling | oxford-uuid:5985ee3f-ba82-44cd-9894-a0e866e55da92023-03-03T13:22:29ZThe PROFILE feasibility study: targeted screening of men with a family history of prostate cancerJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5985ee3f-ba82-44cd-9894-a0e866e55da9EnglishSymplectic Elements at OxfordAlphaMed Press2016Castro, EMikropoulos, CBancroft, EKDadaev, TGoh, CTaylor, NSaunders, EBorley, NKeating, DPage, ECSaya, SHazell, SLivni, NDeSouza, NNeal, DHamdy, FCKumar, PAntoniou, ACKote-Jarai, ZPROFILE Study Steering CommitteeEeles, RA<p><strong>Background.</strong> A better assessment of individualized prostate cancer (PrCa) risk is needed to improve screening. The use of the prostate-specific antigen (PSA) level for screening in the general population has limitations and is not currently advocated. Approximately 100 common single nucleotide polymorphisms (SNPs) have been identified that are associated with the risk of developing PrCa. The PROFILE pilot study explored the feasibility of using SNP profiling in men with a family history (FH) of PrCa to investigate the probability of detecting PrCa at prostate biopsy (PB). The primary aim of this pilot study was to determine the safety and feasibility of PrCa screening using transrectal ultrasound-guided PB with or without diffusion-weighted magnetic resonance imaging (DW-MRI) in men with a FH. A secondary aim was to evaluate the potential use of SNP profiling as a screening tool in this population.</p> <p><strong>Patients and Methods.</strong> A total of 100 men aged 40–69 years with a FH of PrCa underwent PB, regardless of their baseline PSA level. Polygenic risk scores (PRSs) were calculated for each participant using 71 common PrCa susceptibility alleles. We treated the disease outcome at PB as the outcome variable and evaluated its associations with the PRS, PSA level, and DW-MRI findings using univariate logistic regression.</p> <p><strong>Results.</strong> Of the 100 men, 25 were diagnosed with PrCa, of whom 12 (48%) had clinically significant disease. Four adverse events occurred and no deaths. The PSA level and age at study entry were associated with PrCa at PB (p = .00037 and p = .00004, respectively). <p><strong>Conclusion.</strong> The results of the present pilot study have demonstrated that PB is a feasible and safe method of PrCa screening in men with a FH, with a high proportion of PrCa identified requiring radical treatment. It is feasible to collect data on PrCa-risk SNPs to evaluate their combined effect as a potential screening tool. A larger prospective study powered to detect statistical associations is in progress.</p> |
| spellingShingle | Castro, E Mikropoulos, C Bancroft, EK Dadaev, T Goh, C Taylor, N Saunders, E Borley, N Keating, D Page, EC Saya, S Hazell, S Livni, N DeSouza, N Neal, D Hamdy, FC Kumar, P Antoniou, AC Kote-Jarai, Z PROFILE Study Steering Committee Eeles, RA The PROFILE feasibility study: targeted screening of men with a family history of prostate cancer |
| title | The PROFILE feasibility study: targeted screening of men with a family history of prostate cancer |
| title_full | The PROFILE feasibility study: targeted screening of men with a family history of prostate cancer |
| title_fullStr | The PROFILE feasibility study: targeted screening of men with a family history of prostate cancer |
| title_full_unstemmed | The PROFILE feasibility study: targeted screening of men with a family history of prostate cancer |
| title_short | The PROFILE feasibility study: targeted screening of men with a family history of prostate cancer |
| title_sort | profile feasibility study targeted screening of men with a family history of prostate cancer |
| work_keys_str_mv | AT castroe theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT mikropoulosc theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT bancroftek theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT dadaevt theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT gohc theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT taylorn theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT saunderse theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT borleyn theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT keatingd theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT pageec theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT sayas theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT hazells theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT livnin theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT desouzan theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT neald theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT hamdyfc theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT kumarp theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT antoniouac theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT kotejaraiz theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT profilestudysteeringcommittee theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT eelesra theprofilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT castroe profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT mikropoulosc profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT bancroftek profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT dadaevt profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT gohc profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT taylorn profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT saunderse profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT borleyn profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT keatingd profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT pageec profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT sayas profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT hazells profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT livnin profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT desouzan profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT neald profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT hamdyfc profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT kumarp profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT antoniouac profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT kotejaraiz profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT profilestudysteeringcommittee profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer AT eelesra profilefeasibilitystudytargetedscreeningofmenwithafamilyhistoryofprostatecancer |